Latest Insider Transactions at Nova Bay Pharmaceuticals, Inc. (NBY)
This section provides a real-time view of insider transactions for Nova Bay Pharmaceuticals, Inc. (NBY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NovaBay Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NovaBay Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 11
2023
|
Yongxiang Zheng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+50.0%
|
-
|
|
May 11
2023
|
Julie Garlikov Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+50.0%
|
-
|
|
May 11
2023
|
Swan Sit Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
May 11
2023
|
Mijia Wu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
May 11
2023
|
Yenyou Zheng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
May 11
2023
|
Paul E. Freiman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
Dec 06
2022
|
Jeffrey Kunin President, DERMAdoctor, LLC |
SELL
Open market or private sale
|
Indirect |
1
-100.0%
|
$1
$1.81 P/Share
|
|
Dec 06
2022
|
Audrey Kunin Chief Product Officer |
SELL
Open market or private sale
|
Indirect |
1
-100.0%
|
$1
$1.81 P/Share
|
|
Nov 21
2022
|
Jeffrey Kunin President, DERMAdoctor, LLC |
SELL
Open market or private sale
|
Indirect |
5,960
-100.0%
|
$11,920
$2.1 P/Share
|
|
Nov 21
2022
|
Audrey Kunin Chief Product Officer |
SELL
Open market or private sale
|
Indirect |
5,960
-100.0%
|
$11,920
$2.1 P/Share
|
|
Sep 14
2022
|
Jeffrey Kunin President, DERMAdoctor, LLC |
SELL
Open market or private sale
|
Indirect |
291,368
-58.27%
|
$0
$0.16 P/Share
|
|
Sep 14
2022
|
Audrey Kunin Chief Product Officer |
SELL
Open market or private sale
|
Indirect |
291,368
-58.27%
|
$0
$0.16 P/Share
|
|
Sep 14
2022
|
Justin Hall CEO, GC and Director |
BUY
Open market or private purchase
|
Direct |
10,000
+10.73%
|
$0
$0.15 P/Share
|
|
May 21
2022
|
Swan Sit Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
May 21
2022
|
Paul E. Freiman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
May 21
2022
|
Yenyou Zheng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
May 21
2022
|
Mijia Wu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
Dec 06
2021
|
Justin Hall CEO, GC and Director |
BUY
Open market or private purchase
|
Direct |
69,767
+48.81%
|
$0
$0.43 P/Share
|
|
Dec 06
2021
|
Andrew D. Jones CFO |
BUY
Open market or private purchase
|
Direct |
36,765
+22.39%
|
$0
$0.44 P/Share
|
|
Dec 03
2021
|
Audrey Kunin Chief Product Officer |
BUY
Open market or private purchase
|
Indirect |
101,650
+16.9%
|
$0
$0.46 P/Share
|
|
Dec 03
2021
|
Jeffrey Kunin President, DERMAdoctor, LLC |
BUY
Open market or private purchase
|
Indirect |
101,650
+16.9%
|
$0
$0.46 P/Share
|
|
Dec 03
2021
|
Andrew D. Jones CFO |
BUY
Open market or private purchase
|
Direct |
8,690
+8.74%
|
$0
$0.44 P/Share
|
|
Dec 02
2021
|
Audrey Kunin Chief Product Officer |
BUY
Open market or private purchase
|
Indirect |
262,369
+39.71%
|
$0
$0.48 P/Share
|
|
Dec 02
2021
|
Jeffrey Kunin President, DERMAdoctor, LLC |
BUY
Open market or private purchase
|
Indirect |
262,369
+39.71%
|
$0
$0.48 P/Share
|
|
Dec 01
2021
|
Jeffrey Kunin President, DERMAdoctor, LLC |
BUY
Open market or private purchase
|
Indirect |
14,848
+9.84%
|
$0
$0.49 P/Share
|
|
Dec 01
2021
|
Audrey Kunin Chief Product Officer |
BUY
Open market or private purchase
|
Indirect |
14,848
+9.84%
|
$0
$0.49 P/Share
|
|
Nov 30
2021
|
Audrey Kunin Chief Product Officer |
BUY
Open market or private purchase
|
Indirect |
30,000
+19.85%
|
$0
$0.46 P/Share
|
|
Nov 30
2021
|
Jeffrey Kunin President, DERMAdoctor, LLC |
BUY
Open market or private purchase
|
Indirect |
30,000
+19.85%
|
$0
$0.46 P/Share
|
|
Nov 23
2021
|
Jeffrey Kunin President, DERMAdoctor, LLC |
BUY
Open market or private purchase
|
Indirect |
66,133
+42.05%
|
$0
$0.46 P/Share
|
|
Nov 23
2021
|
Audrey Kunin Chief Product Officer |
BUY
Open market or private purchase
|
Indirect |
66,133
+42.05%
|
$0
$0.46 P/Share
|
|
Nov 22
2021
|
Jeffrey Kunin President, DERMAdoctor, LLC |
BUY
Open market or private purchase
|
Indirect |
25,000
+50.0%
|
$0
$0.46 P/Share
|
|
Nov 22
2021
|
Audrey Kunin Chief Product Officer |
BUY
Open market or private purchase
|
Indirect |
25,000
+50.0%
|
$0
$0.46 P/Share
|
|
May 04
2021
|
Andrew D. Jones CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
77,994
-48.75%
|
$0
$0.79 P/Share
|